AJP - Renal Physiology, Vol 273, Issue 6 925-F930, Copyright © 1997 by American Physiological Society

ARTICLES

Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure

N. D. Vaziri, X. Q. Wang and K. Liang
Department of Medicine, University of California, Irvine 92697, USA.

In a recent study, we found marked downregulation of lipoprotein lipase (LPL) gene expression in fat, myocardium, and skeletal muscle of rats with chronic renal failure (CRF). Recently, hepatic lipase expression was shown to be depressed in CRF rats, and parathyroidectomy (PTX) was shown to reverse this abnormality. This study was undertaken to determine whether down-regulation of LPL expression in CRF is due to secondary hyperparathyroidism. Accordingly, LPL mRNA (Northern analysis), protein mass (Western analysis using mouse antibovine LPL monoclonal antibody, 5D2), and catalytic activity of the fat pad and soleus muscle were compared in five-sixths-nephrectomized male rats (CRF), parathyroidectomized CRF rats, and sham-operated control animals. The CRF animals exhibited marked hypertriglyceridemia and significant reductions of fat and skeletal muscle LPL mRNA abundance, protein mass, and catalytic activity (P < 0.05 vs. controls, for all parameters). PTX completely normalized the LPL mRNA, protein mass, and enzymatic activity and partially ameliorated the CRF hypertriglyceridemia (P < 0.05 vs. CRF group, for all parameters). Thus secondary hyperparathyroidism is responsible for impaired LPL expression in experimental CRF. This abnormality is completely corrected by PTX.

This article has been cited by other articles:

				G. R. Adams and N. D. Vaziri Skeletal muscle dysfunction in chronic renal failure: effects of exercise Am J Physiol Renal Physiol, April 1, 2006; 290(4): F753 - F761. [Abstract] [Full Text] [PDF]

				N. D. Vaziri Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences Am J Physiol Renal Physiol, February 1, 2006; 290(2): F262 - F272. [Abstract] [Full Text] [PDF]

				K. Liang, C. H. Kim, and N. D. Vaziri HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure Am J Physiol Renal Physiol, March 1, 2005; 288(3): F539 - F544. [Abstract] [Full Text] [PDF]

				N. D. Vaziri and K. Liang ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure Am J Physiol Renal Physiol, November 1, 2004; 287(5): F1038 - F1043. [Abstract] [Full Text] [PDF]

				N. D. Vaziri, C. H. Kim, B. Dang, C.-D. Zhan, and K. Liang Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure Am J Physiol Renal Physiol, July 1, 2004; 287(1): F90 - F94. [Abstract] [Full Text] [PDF]

				K. Liang and N. D. Vaziri Upregulation of acyl-CoA:cholesterol acyltransferase in chronic renal failure Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E676 - E681. [Abstract] [Full Text] [PDF]